Mail

UK markets closed

FTSE 100
8,285.71
+99.36(+1.21%)
FTSE 250
21,356.30
+471.95(+2.26%)
AIM
779.67
+6.64(+0.86%)
GBP/EUR
1.1844
-0.0006(-0.05%)
GBP/USD
1.2873
+0.0019(+0.14%)
Bitcoin GBP
52,904.98
+686.66(+1.31%)

8 champion homes in Olympic host cities

A selection of properties in former Games cities as Paris 2024 starts

Shield Therapeutics plc (STX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)

Add to watchlist

2.0500

-0.0250

(-1.20%)

At close: 04:04PM BST

Currency in GBp

Valuation measures⁴

Market cap (intra-day)	16.03M
Enterprise value	20.93M
Trailing P/E	53.33
Forward P/E	65.36
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.46
Price/book (mrq)	1.37
Enterprise value/revenue	2.06
Enterprise value/EBITDA	-1.49

Trading information

Stock price history

Beta (5Y monthly)	1.21
52-week change ³	-80.70%
S&P500 52-week change ³	18.96%
52-week high ³	12.8500
52-week low ³	1.0630
50-day moving average ³	1.9070
200-day moving average ³	3.9159

Share statistics

Avg vol (3-month) ³	3.99M
Avg vol (10-day) ³	5.93M
Shares outstanding ⁵	782.06M
Implied shares outstanding ⁶	782.06M
Float ⁸	410.13M
% held by insiders ¹	62.51%
% held by institutions ¹	11.88%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-254.44%
Operating margin (ttm)	-226.15%

Management effectiveness

Return on assets (ttm)	-51.93%
Return on equity (ttm)	-308.60%

Income statement

Revenue (ttm)	13.09M
Revenue per share (ttm)	0.02
Quarterly revenue growth (yoy)	203.30%
Gross profit (ttm)	N/A
EBITDA	-31.08M
Net income avi to common (ttm)	-33.29M
Diluted EPS (ttm)	-0.0400
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	13.95M
Total cash per share (mrq)	0.02
Total debt (mrq)	20.25M
Total debt/equity (mrq)	134.67%
Current ratio (mrq)	2.28
Book value per share (mrq)	0.02

Cash flow statement

Operating cash flow (ttm)	-37.13M
Levered free cash flow (ttm)	-28.96M